MedPath

SLV-341

Generic Name
SLV-341

First in Man Study With SLV341

Phase 1
Terminated
Conditions
Diabetes
Interventions
Drug: placebo
First Posted Date
2009-04-24
Last Posted Date
2010-04-28
Lead Sponsor
Solvay Pharmaceuticals
Target Recruit Count
87
Registration Number
NCT00887445
Locations
🇬🇧

S341.1.001 Site #, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath